MRP ₹3314.5
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Tauritmo 25 mg Soft Capsule belongs to the group of medicines called protein kinase inhibitors used to treat acute myeloid leukaemia (AML). It is sometimes, also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), or mast cell leukaemia (MCL).
Tauritmo 25 mg Soft Capsule contains Midostaurin, which works by blocking the action of kinase enzymes in abnormal cells and stops their division and growth. Thereby, it helps prevent the spread of cancer and mast cells.
Tauritmo 25 mg Soft Capsule may cause certain side effects such as nausea, vomiting, headache, fever, musculoskeletal pain, and upper abdominal pain. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen. Take Tauritmo 25 mg Soft Capsule as prescribed by your doctor.
Discontinue taking Tauritmo 25 mg Soft Capsule and inform your physician if you observe any allergic reactions. Inform the doctor about your health condition and medications to rule out any side effects. Do not take Tauritmo 25 mg Soft Capsule if you are pregnant or breastfeeding. This medicine is not recommended for children as safety and effectiveness have not been established.
Tauritmo 25 mg Soft Capsule is used in the treatment of Acute myeloid leukaemia (AML), aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), and mast cell leukaemia (MCL). The detailed uses of Tauritmo 25 mg Soft Capsule are as follows:
Tauritmo 25 mg Soft Capsule belongs to the group of medicines called protein kinase inhibitors used to treat acute myeloid leukaemia (AML) in patients who are FLT3 mutation-positive. It is also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), or mast cell leukaemia (MCL). Tauritmo 25 mg Soft Capsule contains Midostaurin, which works by blocking the action of kinase enzymes in abnormal cells and stops their division and growth. Thereby, it helps prevent the spread of cancer and mast cells.
Consult your doctor
It is not known if alcohol affects Tauritmo 25 mg Soft Capsule . Please consult your doctor.
Unsafe
Tauritmo 25 mg Soft Capsule is not recommended during pregnancy as it may harm your unborn baby. Therefore, if you are pregnant or planning for pregnancy, talk to the doctor for advice.
Unsafe
Tauritmo 25 mg Soft Capsule may harm the baby. Avoid breastfeeding during treatment with Tauritmo 25 mg Soft Capsule and for at least 4 months after stopping the treatment.
Caution
Tauritmo 25 mg Soft Capsule may cause dizziness and vertigo. Be cautious while driving or operating machinery.
Consult your doctor
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Tauritmo 25 mg Soft Capsule . Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Consult your doctor
If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Tauritmo 25 mg Soft Capsule . Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Caution
The safety and effectiveness of Tauritmo 25 mg Soft Capsule in children below 18 years have not been established.
Caution
Tauritmo 25 mg Soft Capsule may cause QT prolongation, a heart rhythm condition that can lead to serious complications like fainting or irregular heartbeat. If you have heart problems such as heart failure or a history of arrhythmias, your doctor will need to evaluate the risks and may monitor your heart closely during treatment.
Caution
Geriatric patients can take Tauritmo 25 mg Soft Capsule , but doctors usually proceed with caution due to age-related changes in metabolism and organ function. Studies suggest it can be effective and safe in older adults with AML, especially when combined with low-intensity therapies.

Have a query?
Do not take Tauritmo 25 mg Soft Capsule if you are allergic to any of its components, if you are taking medicines used to treat tuberculosis (rifampicin), epilepsy (carbamazepine or phenytoin), prostate cancer (enzalutamide), or herbal products (St. John’s Wort) or if you are pregnant or breastfeeding. Inform the doctor if you have any infections, heart disorders, lung, kidney or liver diseases. Seek immediate medical attention if you experience symptoms of low white blood cell count (fever, sore throat, mouth ulcers), lung problems (fever, chest pain, cough with or without mucous, trouble breathing or shortness of breath), or heart problems (chest pain or discomfort, fainting, dizziness, light-headedness, shortness of breath, blue discolouration of your lips, hands or feet, or swelling of your lower limbs).
Drug-Drug Interactions: Inform the doctor if you are taking medicines used to treat tuberculosis (rifampicin), epilepsy (carbamazepine or phenytoin), prostate cancer (enzalutamide), infections (ketoconazole, clarithromycin), HIV (ritonavir, efavirenz), depression (nefazodone, bupropion), control levels of fat in your blood (atorvastatin, rosuvastatin), muscle relaxant (tizanidine, chlorzoxazone), or herbal product used to treat depression (St. John’s Wort).
Drug-Food Interactions: Do not consume grapefruit and its juice during treatment with Tauritmo 25 mg Soft Capsule as it may significantly increase the blood levels of the medicine.
Drug-Disease Interactions: Inform the doctor if you have breathing or lung problems, irregular heartbeat, QT prolongation, infections, or liver or kidney disease.
Login/Sign Up
Login/Sign Up
RXZydus Healthcare Ltd
₹4119
(₹147.11 per unit)
RXGlenmark Pharmaceuticals Ltd
₹3849
(₹962.25 per unit)
RXDr Reddy's Laboratories Ltd
₹27999
(₹999.96 per unit)
Tauritmo 25 mg Soft Capsule is used to treat Acute myeloid leukaemia (AML), aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), and mast cell leukaemia (MCL).
Tauritmo 25 mg Soft Capsule works by blocking the action of kinase enzymes in abnormal cells and stops their division and growth. Thereby, it helps prevent the spread of cancer and mast cells.
If you miss a dose of Tauritmo 25 mg Soft Capsule , take your next dose at the scheduled time. Avoid taking an extra dose to make up for the missed dose.
Tauritmo 25 mg Soft Capsule may reduce fertility in men and women. Before starting the treatment, discuss with the doctor if you have any concerns regarding fertility.
Continue taking Tauritmo 25 mg Soft Capsule even if you feel well. Do not stop taking Tauritmo 25 mg Soft Capsule without talking to the doctor.
If you vomit after taking Tauritmo 25 mg Soft Capsule , do take another dose. Continue with your regular dosing schedule and take the next dose at your scheduled time. If nausea or vomiting persists or worsens, consult the doctor.
Disclaimer
We provide you with authentic, trustworthy and relevant information